Literature DB >> 13260557

Central serous retinopathy.

G BENNETT.   

Abstract

Entities:  

Keywords:  RETINA/diseases

Mesh:

Year:  1955        PMID: 13260557      PMCID: PMC1324597          DOI: 10.1136/bjo.39.10.605

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  32 in total

1.  Psychogenic ocular symptoms.

Authors:  E S GIFFORD
Journal:  AMA Arch Ophthalmol       Date:  1955-03

2.  Clinical significance of some entoptic phenomena.

Authors:  B S PRIESTLEY; K FOREE
Journal:  AMA Arch Ophthalmol       Date:  1955-03

3.  Multiple stresses, intraocular pressure,. and acute glaucoma.

Authors:  E SCHMERL; B STEINBERG
Journal:  Am J Ophthalmol       Date:  1955-03       Impact factor: 5.258

4.  Choroidopathy.

Authors:  A J BEDELL
Journal:  AMA Arch Ophthalmol       Date:  1954-11

5.  A few cases of retinitis centralis serosa.

Authors:  O CARLBERG; T GAUSLAND
Journal:  Acta Ophthalmol (Copenh)       Date:  1953

6.  Earliest symptoms of diseases of the macula.

Authors:  M AMSLER
Journal:  Br J Ophthalmol       Date:  1953-09       Impact factor: 4.638

7.  Macular degeneration treated with cortisone.

Authors:  H E HOBBS
Journal:  Proc R Soc Med       Date:  1953-03

8.  Central angiospastic retinopathy; a review of the literature and report of one case.

Authors:  R BUXEDA
Journal:  Am J Ophthalmol       Date:  1952-12       Impact factor: 5.258

9.  On the character and management of circulatory disturbances of the central retina.

Authors:  J V V NICHOLLS
Journal:  Am J Ophthalmol       Date:  1952-12       Impact factor: 5.258

10.  Vascular anatomy of the choroid in relation to selective localization of ocular disease.

Authors:  K C WYBAR
Journal:  Br J Ophthalmol       Date:  1954-09       Impact factor: 4.638

View more
  12 in total

1.  [Central serous chorioretinopathy (CSC)].

Authors:  H Baraki; N Feltgen; J Roider; H Hoerauf; C Klatt
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

2.  Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy.

Authors:  L Ficker; G Vafidis; A While; P Leaver
Journal:  Br J Ophthalmol       Date:  1988-11       Impact factor: 4.638

3.  Type A behavior and central serous chorioretinopathy.

Authors:  L A Yannuzzi
Journal:  Trans Am Ophthalmol Soc       Date:  1986

4.  Central serous retinopathy.

Authors:  A Dellaporta
Journal:  Trans Am Ophthalmol Soc       Date:  1976

5.  Six cases of central serous choroidopathy induced by systemic corticosteroid therapy.

Authors:  T Harada; K Harada
Journal:  Doc Ophthalmol       Date:  1985-08-15       Impact factor: 2.379

6.  Angiographic characteristics of central serous chorioretinopathy in an Egyptian population.

Authors:  Maha M Shahin
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

7.  Psychosomatic aspects in patients with central serous chorioretinopathy.

Authors:  C Spahn; J Wiek; T Burger; L Hansen
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

8.  Quality of life of patients with central serous chorioretinopathy - a major cause of vision threat among middle-aged individuals.

Authors:  Izabella Karska-Basta; Weronika Pociej-Marciak; Michał Chrząszcz; Katarzyna Żuber-Łaskawiec; Marek Sanak; Bożena Romanowska-Dixon
Journal:  Arch Med Sci       Date:  2020-01-29       Impact factor: 3.318

9.  The morphology of choroidal neovascularization in chronic central serous chorioretinopathy presenting with flat, irregular pigment epithelium detachment.

Authors:  Claudio Azzolini; Jennifer Cattaneo; Laura Premoli; Cristian Metrangolo; Maurizio Chiaravalli; Simone Donati
Journal:  Int Ophthalmol       Date:  2021-03-21       Impact factor: 2.031

10.  Systemic factors associated with central serous chorioretinopathy in Koreans.

Authors:  Youngsub Eom; Jaeryung Oh; Seong-Woo Kim; Kuhl Huh
Journal:  Korean J Ophthalmol       Date:  2012-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.